West Pharmaceutical Services Profit Margin 2010-2023 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of December 31, 2023 is 20.12%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $27.818B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.728B 18.40
Becton Dickinson (BDX) United States $67.941B 19.73
Cardinal Health (CAH) United States $25.564B 15.37
Align Technology (ALGN) United States $23.702B 47.80
Cooper (COO) United States $18.588B 28.13
Labcorp (LH) United States $17.307B 14.78
Henry Schein (HSIC) United States $9.123B 15.78
DENTSPLY SIRONA (XRAY) United States $6.490B 17.10
Merit Medical Systems (MMSI) United States $4.217B 24.13
STAAR Surgical (STAA) United States $2.433B 76.60
CONMED (CNMD) United States $2.296B 21.62
Patterson (PDCO) United States $2.281B 10.93
Atrion (ATRI) United States $0.703B 36.21
Lifevantage (LFVN) United States $0.080B 12.90
Pro-Dex (PDEX) United States $0.063B 24.05
Biolase (BIOL) United States $0.005B 0.00